Afuco™ Anti-IAV HA ADCC Therapeutic Antibody (Diridavumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to Influenza A hemagglutinin. CR6261 is a monoclonal antibody that binds to a broad range of the influenza virus.
Supplier Creative Biolabs
Product # AFC-TAB-735
Pricing Inquiry
Host Human
Target IAV HA
Species Reactivity Influenza virus
Type ADCC enhanced antibody
Applications Neut, ELISA, IF, IP, FuncS, FC
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback